Africa's isolation from the global clinical research network.
Africa Connectivity
Low
Multi-Region Trials
12%
Europe Connectivity
High
Isolation Index
0.78
Key Finding
Africa exhibited a net-importer topology with approximately 3.2 incoming edges (foreign sponsors conducting trials in Africa) for every outgoing edge (African institutions participating in foreign-located trials).
Africa operates largely in isolation from the global clinical research grid. Only 12% of African trials are part of multi-regional studies, compared to the highly interconnected European and North American networks. This isolation means that African researchers lack access to shared protocols, regulatory harmonisation, and the collaborative infrastructure that accelerates medical discovery.
The Evidence 154 words · target 156
In network analysis of global health research, does Africa's connectivity to the international trial network reflect genuine integration or structural dependency? This graph-theory analysis evaluated collaborator relationships for 23,873 African trials using ClinicalTrials.gov sponsor and collaborator metadata to map directional partnership edges. Investigators reported the ratio of incoming-to-outgoing research edges as the primary estimand for network sovereignty. Africa exhibited a net-importer topology with approximately 3.2 incoming edges (foreign sponsors conducting trials in Africa) for every outgoing edge (African institutions participating in foreign-located trials). The United States showed a balanced ratio of 1.1, while China demonstrated net exporter status at 0.7, indicating sovereign research production exceeding foreign participation. Africa's high connectivity score of 0.9 masked dependency rather than sovereignty since eighty percent of edges originated from Northern institutions. These findings reframe Africa's network position from integration to colonisation. Interpretation is limited by the difficulty of determining the true direction of intellectual contribution within collaborative relationships.
Sentence Structure
Question
In network analysis of global health research, does Africa's connectivity to the international trial network reflect genuine integration or structural dependency?
Dataset
This graph-theory analysis evaluated collaborator relationships for 23,873 African trials using ClinicalTrials.gov sponsor and collaborator metadata to map directional partnership edges.
Method
Investigators reported the ratio of incoming-to-outgoing research edges as the primary estimand for network sovereignty.
Primary Result
Africa exhibited a net-importer topology with approximately 3.2 incoming edges (foreign sponsors conducting trials in Africa) for every outgoing edge (African institutions participating in foreign-located trials).
Robustness
The United States showed a balanced ratio of 1.1, while China demonstrated net exporter status at 0.7, indicating sovereign research production exceeding foreign participation.
Interpretation
Africa's high connectivity score of 0.9 masked dependency rather than sovereignty since eighty percent of edges originated from Northern institutions.
Boundary
These findings reframe Africa's network position from integration to colonisation.